COPENHAGEN, Nov 15 (Reuters) - Danish biotechnology company NeuroSearch (NEUR.CO: Quote, Profile, Research) said on Wednesday it had expanded its alliance with GlaxoSmithKline (GSK.L: Quote, Profile, Research) and put in place a new equity structure under which it could sell shares to Glaxo worth up to 223 million Danish crowns ($38.22 million).
